Unity Biotechnology (STU:9U90) Total Stockholders Equity : €22.07 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Unity Biotechnology Total Stockholders Equity?

Unity Biotechnology's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €22.07 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Unity Biotechnology's Book Value per Share for the quarter that ended in Mar. 2024 was €1.31. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Unity Biotechnology's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.94.

Unity Biotechnology Total Stockholders Equity Historical Data

The historical data trend for Unity Biotechnology's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unity Biotechnology Total Stockholders Equity Chart

Unity Biotechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

108.64

68.13

52.72

52.94

26.04

Unity Biotechnology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															54.76	45.60	33.93	26.04	22.07

Unity Biotechnology (STU:9U90) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Unity Biotechnology's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(22.069	-	0)	/	16.7866
	=	1.31

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Unity Biotechnology's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	20.798)	/	22.069
	=	0.94

Unity Biotechnology Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Unity Biotechnology's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Unity Biotechnology (STU:9U90) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Unity Biotechnology Inc (STU:9U90) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

UBX:USA 9U90:Germany

Address

285 East Grand Avenue, South San Francisco, CA, USA, 94080

Website

https://www.unitybiotechnology.com

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases.

Unity Biotechnology (STU:9U90) Headlines

No Headlines